Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PCSM-TCLPD) is classified as a T-cell lymphoproliferative disorder rather than a true lymphoma in the 2016 World Health Organization (WHO) classification, given its indolent behavior. It can occur at any age, but it most commonly presents in the sixth and seventh decade of life, and it presents equally in men and women.
PCSM-TCLPD typically presents as a single papule, nodule, or plaque on the head, neck, or trunk. In around 25% of cases, more than one lesion is seen. Typically, this is a slow-growing lesion, but there have been cases reported where the lesion can enlarge rapidly. Disease is localized to the skin, follows a benign course, and carries an excellent prognosis.
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder
Alerts and Notices
Important News & Links
Synopsis
Codes
ICD10CM:
D47.9 – Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
SNOMEDCT:
788674000 – Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder
D47.9 – Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
SNOMEDCT:
788674000 – Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
References
Subscription Required
Last Reviewed:01/30/2022
Last Updated:01/30/2022
Last Updated:01/30/2022